The genomic field continues to shed light on COVID-19. The latest: vaccination frequency, new therapy options, and unexpected mutations in the virus.
Other countries can spot new variants because they’re actively looking for them. But the U.S. has spent a year with its head in the sand.
For both clinical and consumer markets, genomic testing has a lot to offer — but it isn’t always used where it could be valuable, and people don’t understand it well enough. As a result, demand...
If the COVID-19 pandemic has taught us anything, it’s that early detection and early action are vital, and that vaccines are what we need most. That’s why we should roll out pathogen surveillance programs based...
We’re prepared to use technology in ways we can't conceptualize, or believe in our wildest dreams, we could use. Medical technology isn’t exempt.
Genomic analysis may still be thought cutting-edge by most people and doctors. But scientists have moved beyond querying DNA to understand a range of new health data about us.
One-third of the world’s arable land has been lost to erosion or pollution. Two Stanford-trained entrepreneurs have developed a tech-centered potential solution.
Genomics is often touted for its potential to improve healthcare, but there’s another emerging field that’s more likely to have a positive impact on patients’ lives: proteomics. Here are some key things to know.